In the third quarter, Asset Management One Co. Ltd. increased its holdings in Medtronic by 2.4%, acquiring an additional 13,594 shares to reach a total of 589,186 shares. This position was valued at approximately 56.11 million dollars at the end of the reporting period. The move underscores the firm’s confidence in Medtronic’s product pipeline and long-term growth prospects within the medical technology sector.

Medtronic continues to attract attention from institutional investors, with overall institutional ownership reaching 82.06% of outstanding shares. Gateway Investment Advisers lifted its stake by 1.6% to 90,237 shares, DMKC Advisory Services added 0.9% to reach 24,230 shares, and Moss Adams Wealth Advisors increased its holding by 3.4% to 4,431 shares. Global Retirement Partners made the largest relative move, raising its position by 17.1% to 33,584 shares. These adjustments reflect a broader trend of steady accumulation by large funds.

In its most recent quarter, Medtronic reported earnings per share of 1.36 dollars, surpassing consensus forecasts by five cents, and revenue of 8.96 billion dollars, beating estimates by 100 million dollars and marking a 6.6% year-over-year increase. Return on equity stood at 14.86% and net margin at 13.71%. The company issued guidance of 5.620 to 5.660 dollars in earnings per share for fiscal year 2026, while analysts collectively anticipate approximately 5.46 dollars for the current fiscal year.

Medtronic declared a quarterly dividend of 0.71 dollars per share, payable on January 16th to shareholders of record as of December 26th, implying an annualized payout of 2.84 dollars and a yield of roughly 3.0%. The company’s dividend payout ratio stands at 76.55%, reflecting its commitment to returning cash to investors while balancing reinvestment in research and development.